Login or sign up Lost password?
Login or sign up
75% reduced risk of liver mortality and SLM (severe liver morbidity), relative to patients without SVR...... Barclay,7 David Wilks,8 Heather Valerio,1,2 Ray Fox,9 Diptendu Bhattacharyya,10 Nicholas Kennedy,11 Judith Morris,12 Andrew Fraser,13 Adrian J. Hutchinson1,2 From the 1School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, United Kingdom; 2Health Protection Scotland, Glasgow, United Kingdom; 3Ninewells Hospital and Medical School, Dundee, United Kingdom; 4University Hospital, Crosshouse, United Kingdom; 5Royal Infirmary Edinburgh, Edinburgh, United Kingdom; 6Gartnavel General Hospital, Glasgow, United Kingdom; 7Glasgow Royal Infirmary, Glasgow, United Kingdom; 8Western General Hospital, Edinburgh, United Kingdom; 9The Brownlee Center, Glasgow, United Kingdom; 10Kirkcaldy Hospital, Fife, United Kingdom; 11Monklands Hospital, Lanarkshire, United Kingdom; 12Southern General Hospital, Glasgow, United Kingdom; 13Aberdeen Royal Infirmary, Aberdeen, United Kingdom; 14Stirling Royal Infirmary, Stirling, United Kingdom Abstract Sustained viral response (SVR) is the optimal outcome of hepatitis C virus (HCV) therapy, yet more detailed data are required to confirm its clinical value.